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Abstract 
Aim:  
         The primary aim is to analyze the clinical profile including 
epidemiology, clinical presentation, diagnosis (ante natal and post 
natal),operative findings, and outcome 
Methods: 
15 Children with Sacro Coccygeal Teratoma were evaluated 
clinically, radiologically, and with tumour markers. Subsequently they 
were subjected to management protocol which included surgery, 
chemo therapy, and radio therapy. They were followed for 2 years 
Observation and results 
 In our study females were more affected, surgery alone 
was inadequate for successful management of malignant SCT. We had 5 
immature teratoma. Altman type 1 type2 were more common, 46% 
presented at birth, benign SCT had favorable prognosis, 13% had a pre 
natal diagnosis, 67% were term, renal anomalies were the most 
common associated anomaly.  
Conclusion 
  SCT are a relatively uncommon tumour. Those presenting 
within a few days of birth carry a better prognosis. Mass is the most 
common presenting symptom. Early diagnosis, prompt surgical 
intervention gives good result and long term survival. The optimal 
therapeutic program for children with malignant SCT is still evolving. 
KEY WORDS 
       Sacro Coccygeal Teratoma, Altman type, tumour marker  
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INTRODUCTION 
Sacrococcygeal Teratoma is a neoplasm arising from the caudal 
end of spine, usually protruding from the inferior end of the spinal 
column and displacing the anus forwards.       
Sacro Coccygeal Teratoma is defined as a tumor emerging from 
the proliferation of pluri potent cells. They contain tissues from one or 
more germ cell layers.  
Though rare it is the most common tumor in the new born period 
with incidence of 1:35000-45000 live births. Male female ratio is 1:  3-4. 
They are composed of 2 or 3 germ cell layers, having multiple tissue 
types. They present in varying sizes and shapes.  
Sacro Coccygeal Teratoma is tumor of new born which carries 
good prognosis if diagnosed early and adequate surgical treatment is 
prompt. 
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AIMS AND OBJECTIVES 
The primary aim is to analyze the clinical profile including   
epidemiology, clinical presentation, diagnosis (ante natal and post natal), 
operative findings, and outcome. 
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REVIEW OF LITERATURE 
HISTORY 
Historically, teratomas were attributed to demons, sexual 
misconduct and abnormal fertilization.1 
Virchow in 1869 applied the term teratos (“of the monster “) and 
onkoma (“swelling “). 
EMBRYOLOGY 
Teratoma is considered to have many tissues, foreign to the 
organ/site from which they are said to arise.2 
Earlier teratomas were thought to have three embryonic layers 
(Ectoderm, endoderm, and mesoderm).  
But in the recent past monodermal types have been included .2,3 
Teratomas were perceived to arise from totipotent primordial germ 
cells.3,4  They develop among the endodermal cells of the yolk sac near 
the origin of the allantois  and migrate to the gonadal  ridges during 4th  
and  5th  weeks of pregnancy. 5 
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                                            EMBRYOLOGY 
 
 
Some of these miss the target and give rise to teratoma anywhere, 
commonly in the midline. 
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Another proposed theory is that they arise from remnants of 
primitive streak/ node - Hensen node. 5-7 
During the third week of gestation, midline cells at the caudal end 
of embryo divide rapidly and by the processes called gastrulation give 
rise to all the three germ cell layers of the embryo. 
By the completion of the third week, primitive streak shortens and 
disappears. This is said to explain the more common occurrence of 
teratoma in the sacro coccygeal region. 
Teratomas have diversity of tissues and varying degree of 
organization of these tissues. 
They may contain skin elements, neural tissue, teeth, fat, cartilage, 
and intestinal mucosa often with normal ganglion cells. 
Tissue architecture is variable. 
Spectrum of cellular differentiation exists. 
Most benign teratoma are composed of mature cells, 20-25% also 
contain immature elements. (Neuro epithelium) 
PATHOLOGY 
Teratoma is the result of continued multiplication of totipotent cells 
from Hensen node which fails to involute at the end of embryonic life. 
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DEFINITION: 
WILLIS  
  “A teratoma is a true tumor or neoplasm composed of multiple 
tissues of kinds foreign to the part in which it arises.” 
Most common site is the Sacro coccygeal region. 
ROBBINS  
 ‘A tumor composed of cells representing more than one germ cell 
layer in which any one tumor cells can vary from totally benign  
(mature ) to cells  that appear frankly malignant. (Immature) 
Risk of malignancy depends on  
1. Age of diagnosis of the disease. 
2. The site of occurrence,  
3. Extent of disease.  
Age greater than 2 years has high risk of malignancy. 
Altman et al classified Sacro coccygeal teratoma into 4 types. 
1. Occur almost exclusively exterior with a minimal pelvic/presacral 
component.  
2. Apart from the External presentation they have significant pelvic 
component.  
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3.  They have intra pelvic and intra abdominal component greater 
than the external component.  
IV They are almost exclusively Pre sacral.  
                          ALTMAN CLASSIFICATION 
 
 
            Type III         Type IV 
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INCIDENCE OF MALIGNANCY 
Altman Type Incidence (%) Malignancy (%) 
I 47 Rare 
II 35 6 
III 8 20 
IV 10 8 
 
ASSOCIATED ANOMALIES; 
Sacro coccygeal Teratomas are usually isolated lesions. 
They form a part of Currarino triad .The triad includes 
   1.   Ano rectal malformation 
   2.   Sacral anomaly 
   3.  Pre Sacral masses. (Usually a teratoma or an Anterior Meningocele.) 
Familial pre disposition is noted in 57% of cases and has an 
autosomal dominance. 
The most common Ano rectal malformation is Anal or Ano rectal 
stenosis. 
Other associated anomalies are 
 Hypospadias. 
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Vesico ureteric reflux. 
Vaginal / uterine duplication. 
Congenital dislocation of hip (7%)  
Vertebral anomalies which leads to late orthopedic sequalae. 
Central nervous system associated anomalies are  
Anencephaly 
Trigonocephalay. 
Dandy Walker Malformation. 
Spina Bifida. 
Myelomeningocele. 
Another peculiar association is with family history of twins. (10 %) 
Teratomas are just one end of the spectrum of conjoined twinning. 
PRESENTATION: 
Post natal 
The most common presentation is a large sacral mass seen at birth. 
Malignant tumor is more common when the child presents at 5 – 6 
months of age as a swelling in the buttock. 
10 
 
 
Ante natal 
Recently most cases are detected by routine antenatal 
ultrasonogram   
                    ANTE NATAL ULTRASOUND 
 
Majority of them die before birth as mostly they are as great as or 
greater than the rest of the   fetus. They die from heart failure as the fetus 
heart is not able to pump sufficient blood to both the fetus and the mass. 
In most of the antenatal series  
    Fetal hydrops/ non immune are very common and are associated with 
increased incidence of fetal death. 8,9,10,11-16 
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DURING LABOR 
Another mode of presentation is when the tumor becomes impacted 
during delivery causing death of the fetus by obstructing delivery or 
tumor ruptures during delivery and the infant bleeds to death shortly after 
birth. 
 
CLINICAL FEATURES. 
The commonest mode of presentation to the pediatric surgical 
department is a large skin covered mass protruding from the coccygeal 
region, pushing the anus and vagina anteriorly. They have large veins on 
the surface. Large tumors may have ruptured / bled or have ulcer on the 
surface.  
Urinary tract obstruction and constipation symptoms precede Sacro 
coccygeal Teratoma detection in infants. 
12 
 
 
                        COMMONEST PRESENTATION -MASS  
 
Malignant tumor commonly present as a rapidly growing buttock mass. 
Distant metastases at presentation are rare due to early diagnosis by ante 
natal ultrasonogram. 
Risk of malignancy is  
                               < 10 % at birth 
                              >75 % at one year of age. 
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Children and adolescent with pre sacral mass present with constipation 
and urinary retention.17,18,19-21 
Diagnosis of pure intra pelvic teratoma is delayed because of non specific 
symptoms like constipation, urinary retention, abdominal mass, and 
symptoms of malignancy (failure to thrive). 
Lesion with large intra pelvic component may cause urinary obstruction. 
Retro rectal mass is recognized on per rectal examination as solid pre 
sacral mass.  The Tumor is firmly attached to or arises from the anterior 
surface of the coccyx. The coccyx is displaced posteriorly. The sacrum is 
normal.  
Blood supply is from the middle sacral artery. 
DIFFERENTIAL DIAGNOSIS. 
1. Anterior meningocele:          It is cephalad to sacrum and is covered 
by duramater. During examination when pressure is applied on the 
mass it causes a bulge in the anterior fontanelle. (Positive cross 
fluctuation). On per rectal examination a cystic mass can be felt 
and the anterior sacral defect can also be palpated. 
2. Sacro coccygeal chordoma. 
3. Lymphangioma 
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4. Lipoma 
5. Tail like remnants.  
6. Meconium pseudo cysts. 
 
DIAGNOSIS: 
Presents as a visible mass at birth.  
Many present as asymptomatic mass but some present with high output 
cardiac failure, Disseminated intravascular coagulation, rupture, bleeding, 
lethal hyperkalemia ( due to tumor necrosis) and prematurity requiring 
intensive care management. 
Plain X Ray of pelvis with spine:  AP & lateral 
1. Differentiates from anterior meningocele which has a characteristic     
defect in the sacrum.  
2. Tumor calcification.   
3. Spinal defects. 
Ultra sonogram of abdomen, pelvis & spine: 
      Gives an assessment of the size, consistency of any pelvic or 
abdominal component.  
15 
 
 
MAGNETIC RESONANCE IMAGING: 
It can be used in neonates with minimal sedation but most require general 
anesthesia. It delineates the vascular anatomy, 22-24 Oil instilled into 
rectum during the scan can be used as a contrast medium.25,26  It clearly 
distinguishes Sacrococcygeal teratoma from Anterior meningocele. It can 
also detect occasional extension of the tumor through sacral hiatus into 
spinal canal.27  
MRI PELVIS: T1 IMAGES 
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MRI PELVIS: T2 IMAGES
  
 
                  
 
 
 
 
 
               
 
Further pre operative studies are unnecessary in most new born. 
 
PRE NATAL DIAGNOSIS 
Second trimester ultra sonogram defines the site of the lesion, 
complex appearance, intra pelvic extension with or without urinary tract 
obstruction. 
Presence of a large solid vascular component is associated with 
significant mortality both in utero and perinatal period.28-31 
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Ante natal MRI:  
 Defines the anatomy of the tumor, and the blood supply to the 
tumor in utero. There is no need for fetal sedation or paralysis 
Perinatal mortality is related to pre maturity, tumor rupture with 
exsanguinations or both. 
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NATURAL COURSE: 
Pre mature delivery may occur spontaneously from 
polyhydramnios or may be induced urgently because of fetal distress. 
Repeat ultra sonogram is a must for ante natally detected tumors. 
Lower segment caesarean section is considered if tumor is greater 
than 5 cm or greater than fetal Bi parietal Diameter. This is to avoid 
dystocia during vaginal delivery and is an obstetrical night mare which is 
avoidable. 
Management of unexpected cases with dystocia is emergency 
caesarian section, completion of partially delivered fetus who has been 
intubated and ventilated after vaginal presentation of head. 
MANAGEMENT 
ANTENATAL 
Fetal MRI is an adjunct to pre natal evaluation to provide 
additional information that helps in counseling and pre operative  
planning 52 
Fetal MRI also helps in differential diagnosis when the lesion is 
entirely pre sacral.53 
Intra uterine laser ablation can be done 54 
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The improved diagnosis and almost uniform mortality rate 
associated with fetal hydrops have provided considerable impetus to 
consider fetal surgery or per cutaneaous shunting or drainage to allow 
vaginal delivery for selected cases of ante natally diagnosed sacro 
coccygeal teratoma. But the results are mixed. 
Interrupting the high vascular flow to the tumors with radio 
frequency ablation.55 
Per cutaneaous aspiration to facilitate delivery31,56 to eradicate 
uterine irritability or prevent tumor rupture at delivery. 
Pre natal decompression using cyto amniotic shunt to relieve 
obstructive uropathy. 
It would be fair to say that the role of fetal intervention in the 
presence of this tumor is not well defined. 
 
POST NATAL MANAGEMENT: 
 
Recently multi modality treatment approach has resulted in improved 
survival of more than 80% of sacrococcygeal teratoma. 
. 
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Preliminary abdominal procedure is to be considered in case of a 
very large tumor. 
     ALTMAN TYPE III – ABDOMINAL APPROACH 
 
Laparoscopic procedure to divide the middle sacral artery has also 
been described. 
Complete excision with coccygectomy is done as soon as the 
neonate is stable enough to undergo the surgery. 
Serum tumor marker is done before surgery and later for 
comparison. 
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PRE OPERATIVE MANAGEMENT: 
If the tumor is intact and the child stable then there is no need for 
an emergency resection. Surgery done within the first 24 hours of birth 
has a good prognosis and the rate of complication is less as the gut is 
usually not colonized in the first 24 hours of life. Early resection 
decreases the rate of infection even if the field is contaminated by stool 
during resection as the gut is not colonized in the first 24 hours of life. 
The new born is started on antibiotics immediately and the same has to 
continue for 24 – 48 hours post operation. Bowel preparation formally 
has to be done if the infant is several days old or has been fed. 
Blood for alpha feta protein is to be taken as a base line in order to 
confirm post operatively that its level falls at the normal rate.10,57-59 
Rarely alpha feta protein might not be elevated. Adequate cross matched 
blood has to be reserved before surgery. Good venous access has to be 
obtained. Consider an arterial line if possible. If tumor ruptures, then 
pressure bandage may stem blood loss but carries the risk of “squeezing” 
immature cells into the venous drainage and lodge these cells in lungs. 
Metastatic disease is not a problem in these infants. Emergency surgery is 
indicated in these circumstances. When the mass is as large as a fetus, 
one should not wait for the baby to grow, but the tumor has to be resected 
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as the incidence of malignancy is said to increase with age more 
particularly if the infant is 2 month old.  
 
SURGICAL PROCEDURE: 
              BLADDER CATHERIZED AND RECTUM  PACKED 
 
 The child is placed in the prone position with a roll under the hips. The 
bladder is catheterized.  The anus /rectum are packed with a betadine 
gauze pack. The anus is prepped out of the field.60,61 The incision is a 
chevron or a vertical on the dorsum of the mass preserving  as much of 
23 
 
the skin as possible. Excess skin can always be trimmed later. Large veins 
in the sub cutaneaous plane are divided between ties. The apex of the 
chevron should be situated over the sacrum.  
                     POSITION ON OPERATING TABLE 
 
If significant intra pelvic or intra abdominal component is present, begin 
with laparotomy /laparoscopy. Preliminary abdominal exploration is also 
indicated when 
1. There is rupture or bleeding,  
2. Pre mature baby in hyper dynamic state and 
3. When preliminary devascularization is needed to stabilize the child.  
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En bloc excision including coccyx is preferable. Failure to excise the 
coccyx is associated with a high recurrence rate.67-69 
                                    OPERATIVE STEPS 
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The options available for the management of large sacro coccygeal 
teratoma are 
1. Intra operative snaring of aorta 62,63 
2. Laparoscopic clipping of middle sacral artery.64 
3. Use of ECMO and hypothermic perfusion. 
4. Devascularization and staged resection 65 
5. Pre operative embolization. 
6. Radio frequency ablation. 
7. Autologous cord blood transfusion is a useful adjunct.66 
POST OPERATIVE MANAGEMENT: 
The child is nursed in the prone position. The urinary catheter is 
removed as soon as the child is stable. The child is fed as soon as it is 
extubated. The drain is removed in the first few days. Alpha feta protein 
is determined in the immediate post operative period and on discharge.  
In the older patients, treatment of the malignant tumor is excision and 
chemotherapy and monitoring with imaging studies and serum markers. 
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For unresectable tumors biopsy and chemotherapy followed by excision 
of the primary tumor after adequate reduction in the size of the tumors 
has been obtained.44 
Radiation therapy is usually reserved for local recurrence of the 
malignant tumor. The child with malignant tumor has be be enrolled in 
pediatric co operative study or treat according to their guidelines. 
COMPLICATIONS OF SURGERY: 
1. Nocturnal enuresis. 
2. Perineal anesthesia 
3. Patulous anus. 
4. Neurogenic bladder. 
5. Urinary and fecal incontinence. 
Modern chemotherapy has produced very good improvement in 
survival.41,42  Survival rates as high as 80 %has been noted but the risk of 
late recurrence or second cancer persists. Functional results in survivors 
are related to fecal and urinary continence problems. Good outcome 
requires meticulous dissection along tumor capsule, 
preservation/reconstruction of muscular structures. 
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FOLLOW UP/MONITOR: 
Physical examination and per rectal examination and tumor 
markers. 
Every 2 months for 3 years because most recurrence occur in 3 years of 
surgery. 43  
In the long term follow up early assessment of bladder, anorectal and 
sexual function along with cosmetic results within a structured oncology 
follow up program is ideal. 
At monthly intervals for 3 months. 
At three monthly intervals for 1 year. 
At six monthly intervals for 1-3 years. 
At yearly intervals for 3- 5 years. 
At each visit the following procedures are performed, 
1. Per rectal examination to rule out local recurrence 
2. Serum alpha feta protein for distant spread.  
3. Renal ultra sonogram. 
Follow up continues for 5 years.  
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PROGNOSIS: 
Good Prognostic factors 
1. Fetus with tumors diagnosed in utero, the survival is greater than 90 %, 
if it is diagnosed by routine ultra sonogram. 
2. Tumour is small.  
Bad Prognostic factors 
1. When polyhydramnios with a larger tumor is present. 
2. When tumor is larger than fetal bi parietal diameter.  
3. As tumor enlarges, fetus develops placentomegaly or hydrops which 
are harbinger of impending fetal death. This should lead to urgent Lower 
segment caesarian section especially when the maternal mirror syndrome 
is present. 51 
In the absence of distal metastasis at presentation and if surgery has 
removed the complete tumor, life expectancy is considered to be normal. 
Prognosis for malignant Sacrococcygeal Teratoma is not good and 
guarded. 
The mortality increases by 60%if the pregnancy is complicated 
which has been an indication of ultrasonographic evaluation.  
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The mortality is 100 % if hydrops or placentamegaly occurs.29-31  
The mortality is said to be 50% if the size of the tumor is 10 cm or 
greater that were highly vascular or fast growing.  
In the absence of severe prematurity and intra partum 
complication, prognosis depends on presence of malignancy and is hence 
related to the age of operation and completeness of excision.  
Cystic lesions are benign but the presence of solid component 
indicates malignancy. 
 The risk of recurrence is increased with the findings of immature 
histology and incomplete resection. 
 Although malignant recurrence of a benign teratoma may be as 
high as 10 – 19%.7,32 the original benign diagnosis may have been due to 
sampling error, 33 an undetected residual microscopic focus of malignant 
tumor 34 or secondary to incomplete coccygectomy at the initial 
operation. 35 
Those tumors which are resected after the new borne period have a 
higher risk of malignant recurrence, especially when an elevated alpha 
protein is present at diagnosis. 
 Elevated alpha feta protein signifies the presence of malignancy in 
the original tumor.33,37  
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Prognosis is not dependent on Altman classification 38 but rather on 
tumor size, physiologic consequences, histology, and associated 
anomalies. The prognosis of malignant tumor depends on tumor type, 
stage 39location and patient age. The recurrent disease is usually local, but 
metastasis occurs to inguinal nodes, lungs, liver, brain and peritoneum 
(pseudomyxmo peritonei). 40 The prognosis of malignant tumor was 
dismal till the advent of platinum based chemotherapy.34 
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MATERIALS AND METHODS: 
 
Study population:   All patients who presented to our hospital with 
sacrococcygeal teratoma. 
Number of cases:  15. 
Study period:         December 2011 to December 2013. 
Exclusion Criteria:  All sacro coccygeal tumors not proven to be teratoma   
e.g. Hind gut duplication cyst, Dermoid, Meningocele, Pelvic tumors – 
Neuro blastoma. 
Screening Procedure:   All cases of sacro-coccygeal tumors were 
examined in detail and subjected to X-ray Pelvis and chest, Ultra 
sonogram, CT / MRI and alpha feta protein. 
FOLLOW UP:   Monthly follow up for 1 year, then two monthly follow 
up till the end of the study. 
 
METHODOLOGY: 
All cases of Sacro coccygeal teratoma detected both ante natally 
and post natally were examined clinically.  
32 
 
 
Investigation protocol:   
All the patients underwent the following investigations-  
X ray chest, Ultra sonogram of abdomen, pelvis and the swelling 
and CECT / MRI if feasible. The tumor markers alpha feta proteins, beta 
HCG and LDH were done. Cardiac evaluation was done before surgery. 
Genetic work up was also done. The patients then went for management 
as per the protocol either upfront surgery or surgery after neo adjuvant 
chemotherapy. 
The standard procedure was WIDE LOCAL EXCISION WITH 
COCCYGECTOMY. Type I and II were approached from the perineum. 
Type III and Type IV were approached initially through abdomen and 
followed externally as required. Neo adjuvant chemotherapy was given 
for inoperable tumors and metastatic tumors. Adjuvant chemotherapy 
with or without radiotherapy was given based on the grade of the tumor 
and the resection margins positivity.  
All the patients were followed till the end of 2 years of study.  
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                           OBSERVATIONS AND RESULTS: 
 
 
AGE: 
In our study 12 patients (80%) were diagnosed before one month of age 
and the remaining 3 patients were diagnosed later. 
 
 
 
Age No of Patients 
Day 1 6 
Day 3-11 5 
Day 24 1 
8 months 1 
1 year 2 
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GENDER PREDILECTION: 
In our study sacrococcygeal teratoma were more common in females (13) 
than in males (2). 
 The ratio M: F is   1: 6.5     
Male 2 
Female 13 
 
0
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7
Day 1 Day 3-11 Day 24 8 months 1 year
No of Patients
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DIAGNOSIS:  
In our study two cases were detected antenatally, and others were 
diagnosed postnatally. One neonate of a twin pregnancy had 
sacrococcygeal teratoma detected in the post natal period. 
 
  
 
 
Male
Female
Ante natally diagnosed 2 
Post Natally diagnosed 13 
36 
 
 
 
CLINICAL FEATURES: 
Though ante natal diagnosis is the most common mode of detection 
but in our study 12 patients were diagnosed in the neonatal period of 
which two had been diagnosed by ante natal ultra sonogram and the rest 
postnatally. 3 patients were diagnosed when they presented with 
constipation and obstructive urinary symptoms.  
Diagnosis Patients 
Ante natally 2 
Neonatal period 10 
Infancy  3 
 
0
2
4
6
8
10
12
14
ante natal diagnosed post natal diagnosed
37 
 
 
ALTMAN TYPE:   
In our study we found type 2 to be the commonest (46%) and type 4 to be 
the least common (6%). 
 
Type  1 4 
Type  2 7 
Type  3 3 
Type  4 1 
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Histological types:  
 
In our study comprised 10 patients (66 %) had mature teratoma 
Mature teratoma 10 
Immature teratoma 5 
 
 
Management: 
 
Primary surgery with wide local excision and coccygectomy were 
done in 12 patients. 
Neo adjuvant chemotherapy was started in 2 patients based on 
level of tumor markers and were followed with wide local excision. 
No of Patients 
mature teratoma
Immature teratoma
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Neoadjuvant chemotherapy and radiation therapy was given to 1 
patient who succumbed to the illness before surgery. 
The chemotherapy regime followed in our institute is PEB regime 
 
 
Management methods No. of patients 
Primary Surgery 12 
Neo adjuvant chemotherapy 2 
Neo adjuvant chemo therapy and 
radiation therapy 
1 
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Management Methods 
 
 Tumor markers: 
  Estimation of alpha feta protein, beta human chorionic 
gonodotropin and lactate de hydrogenase were done in all cases.  
Alpha feto protein was elevated in 5 cases (33%); it was within normal 
range in 10 cases (66%).  
Tumor markers Increased Normal 
Alpha feta protein 5 10 
Beta HCG NIL - 
LDH NIL - 
 
No of Patients
Primary Surgery
Neo adjuvant 
chemotherapy
Neo adjuvant chemo 
radiation
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The presence of the tumor marker did not correlate with the tumor 
grade. The tumor marker was used primarily to monitor the progress of 
the disease and as a prognostic marker. 
MODE OF DELIVERY: 
Out of 15 patients 9 (60%) were delivered by LSCS and the rest 
had normal vaginal delivery. 
 
 
Associated anomalies: 
The most common associated anomalies were renal followed by 
CVS and others. 
  
Patients
LSCS
NVD
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PROGNOSTIC FACTORS  
The Poor prognostic factors are 
1. solid tumors 
2.  detected early in pregnancy 
3.  malignant histological types  
4. polyhydramnios  
5. placentamegaly  
6. Fetal hydrops. 
Prognosis Patients 
Poor/adverse factors 5 
No adverse factors 10 
 
Patients
renal
others
none
43 
 
    
PROGNOSTIC FACTORS 
 
Poor prognostic factors Patients 
polyhydramnios 2 
Immature teratoma 2 
Detected early in pregnancy 1 
 
       
  
Patients
Adverse
No Adverse
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Poor Prognostic Factors 
 
MORTALITY: 
During this study period one patient died during Neoadjuvant therapy 
while others were disease free till the completion of this study. 
 
Patients
Polyhydramnios
Immature teratoma
Detected early in pregnancy
Patient
death
improved
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DISCUSSION 
Discussion: 
Sacrococcygeal teratoma is a congenital tumor. Incidence is 1 in 
40,000 new born. It arises from the caudal end of the spine with different 
sizes and shapes of protrusion. Most of them are benign and well 
differentiated and hence have a good prognosis after complete surgical 
excision. 45 
It is composed of one or more germinal cell layers originating from 
pluripotential cells, yet it lacks complex tissular organization. The new 
born with Sacrococcygeal teratoma  has excellent prognosis depending on 
the time of diagnosis and when the surgery was performed , the malignant 
potential of the tumor and the ease with which  surgical resection was 
performed .46  
Although about 75% of cases are seen in females, the exact reason 
for the female preponderance is not fully understood. 47,48 
Apart from age at diagnosis and treatment, and the extent of 
resection, the prognosis is also determined by the histological type and 
Altman type at the time of resection, and not the size of the tumor 49 
Follow up in patients with SCT is necessary especially during the 
first three years of treatment when recurrence is most likely.50 
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 Extensive surgery in the pelvic and perineal region may involve 
disruption of nerves and muscles which supply the urinary /ano rectal 
sphincters which are necessary for continence. Our follow up period was 
for 2 years and we did not encounter any incontinence to micturition and 
defecation. Longer period of follow is however required, to identify late 
incontinence problem to micturition and defecation. 
In our study females were more affected (86%) which is also in 
accordance with a study reported by Raney RB Jr et al from Children’s 
hospital of Philadelphia between 1971 and 1980(66%) and also the study 
done by Bilik R et al Ontario, Canada. as well as by Chirdan JB et al ,Jos 
Nigeria who had a female preponderance of 81 %. 
Their study also concluded that surgery alone was inadequate for 
successful management of malignant SCT which is in concordance with 
our study also. 
Our study of 5 immature teratoma had neo adjuvant and adjuvant 
therapy.  Our study correlates with their study for successful management 
of malignant SCT. 
In our study Altman Type I and II were more common as also 
reported by Bilik R et al at the University of Toronto, Ontario, Canada 
from 1972 to 1990 in which they studied 36 patients.  
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In another study from Wakhlu A et al from Department of pediatric 
Surgery, King George Medical College, Lucknow, UP, India a 
retrospective study of 72 patients over a period of 17 years found that 
1. The sex incidence was nearly equal (ours had a female preponderance) 
2. There was a high proportion of Altman type IV.  (We had type II)  
3. 66 % presented beyond neo natal period (ours 46% presented at birth) 
In a study by Perrelli L et al Catholic University of the Sacred Heart, 
Rome, Italy they studied 17 cases between July 1985 and December 1998 
found that Benign SCT had favorable prognosis .Our study too supported 
this theory. 
 Negative prognostic factors were  
1. Solid tumors,  
2. Those detected early in pregnancy,  
3. Malignant histotypes,  
4. Polyhydramnios  
5. Placentomegalay, and 
6. Fetal hydrops,  
                        Ours also corroborated with this study. 
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In a study by Swamy R from New Castle Medical Service observed 
a pre natal diagnosis in 50 % of cases were as we had only 13 %. 
In a study by Chirdan JB, et al from pediatric Surgery Unit, Jos 
University Teaching Hospital, Jos, Nigeria between Jan 1990 and May 
2008 in 38 children concluded that  
1. 23 patients (60 %) presented in the neo natal period in their study 
were as in ours 46% presented in neo natal period. 
2. Most of their patients had significant external tumors and in our 
study we had 46% type 2 tumors and majority of the tumors were 
external. 
3. Their histology was mainly benign; in our study we had mature 
teratoma of 10 patients (66 %.) only. 
In a study done by Ho KO, et al at the clinical school, University of 
Sidney, New South Wales, Australia between January 1996 and 
December 2008 had 17 infants with a diagnosis of SCT. 
1. 70 % were born at term. Ours had 67 % at term child. 
2. 47 % had a pre natal diagnosis. Ours had a pre natal diagnosis of 
13 %. 
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3. Associated anomalies were seen in 41 % in their study with renal 
anomalies being the most common; we in ours had associated 
anomaly of80 % of which renal anomaly was common with 53 %. 
4. Their study had an incidence of mature teratoma as 50 %, in our 
study we had 66% of mature teratoma. 
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CONCLUSION 
Sacrococcygeal Teratomas are a relatively uncommon tumor 
affecting neonates, infants and children. Sacrococcygeal teratoma has a 
female preponderance. 
Those presenting within a few days of birth carry a better prognosis 
than those detected later in infancy. 
Benign Sacrococcygeal Teratomas generally have a favorable 
prognosis. 
Benign Teratomas have a significant recurrence rate mandating 
follow up for more than 3 years. 
Most of Sacrococcygeal teratoma present within the first few 
weeks of life. 
Mass is the most common presenting symptom. 
Early diagnosis, prompt surgical intervention, gives good results 
and long term survival. 
Lower segment caesarian section as the mode of delivery is 
considered when the size of the mass is more than the Bi parietal 
Diameter of the fetus. When there are no other obvious indications for 
Lower segment caesarian section, normal vaginal delivery is considered. 
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Among the associated anomalies, the most common anomaly is 
renal anomaly. 
With advancing radiological imaging, early diagnosis is possible 
followed by appropriate management and long term survival. 
The overall survival of neonatal sacrococcygeal teratoma is high. 
Tumor markers are used for monitoring the disease rather than the 
assessment of the grade of the disease. 
Important components of management include timely diagnosis, 
multidisciplinary planning, (surgery, radiotherapy and chemotherapy) 
long term follow up, and intervention for functional sequelae. 
Poor prognostic factors include solid tumor, those detected early in 
pregnancy, malignant histotypes, polyhydramnios, placentamegaly, and 
fetal hydrops. 
Surgical resection alone is adequate therapy for non metastatic 
malignant tumor. 
Cisplatin based chemotherapy has improved the survival of 
patients with malignant tumor. 
Surgery alone is inadequate for successful management of children 
with malignant sacrococcygeal teratoma. Chemotherapy with PEB 
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(Cisplatin,Etoposide , Bleomycin) can be effective when combined with 
radiation, but fatal pulmonary toxicity can result from such  combined 
therapy. 
After Surgery sequelae of Sacrococcygeal teratoma tends to 
improve with time. 
While sacrococcygeal teratoma is usually benign, recurrent malignant 
transformation in patient who present late and long term functional 
sequelae are problems that must be tackled by the care givers. 
The optimal therapeutic program for children with malignant SCT 
is still evolving. 
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                       Informed Consent Form 
 
I/We,……………………………………………………………………… 
related to  Baby/child of…………………………………… 
As…………………………………………….. , herewith consent to 
enroll in the study Titled “A study of clinical profile management 
&outcome of Sacrococcygeal Teratoma in children” profiling conducted 
by Dr. K. SRIRAM as a part of his thesis for MCh, (Pediatric Surgery) 
post Graduation. I / We have been fully informed about the Study 
process, I / we have been reassured about the confidentiality of  our 
baby’s identity. I / we know that we can withdraw from the study at any 
time without affecting the care and treatment of our baby/child 
 
Witness 1 
Signature: 
Address: 
 
 
Witness 2                                              Signature of parent/ Guardian 
Signature:                                              Place: 
Address:                                                Date 
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Sacro Coccygeal - Proforma 
Personal details – 
 
Name    Age    Sex 
 
I.P.No: 
 
Address: 
 
D.O.A:   D.O.S:    D.O.D: 
 
Antenatal scan: 
Done: 
 
Report – 
            Not done: 
 
Clinical symptoms: 
 
Ante natal Diagnosis. 
 
Post Natal :   Mass 
 
others 
 
                                     
Associated anamoly: 
 
Investigation: 
Ante Natal Ultrasonogram 
 
Post Natal : 
 
X ray No: 
 
Chest: 
Abdomen: 
Spine: 
Mass. 
59 
 
Ultrasonogram Abdomen/Cranium/mass 
 
Echo cardiogram. 
 
Magnetic resonance imaging (MRI) 
 
Tumor Markers 
 
Altman Type: 
 
 
Treatment: 
 
Surgery: Primary or adjuvant. 
 
Chemotherapy: Adjuvant or Neo adjuvant. 
 
Radiotherapy. 
 
Surgical details 
 
Intraoperative finding: 
 
 
HPE report: 
 
 
Adjuvant therapy. 
 
 
 
Follow up of patient: 
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MASTER CHART 
S.No Name Age Wt Sex IP no Delivery A/N USG MRI 
Altman 
type Management HPE Markers 
1 b/o vinodhin D10 2.8 F 750136 NVD NIL YES 2 Surgery Mature N 
2 b/o jayalakshmi D11 3.0 M 788447 LSCS NIL YES 1 Surgery Mature N 
3 b/o  rasigapriya D1 3.0 F 776661 NVD NIL YES 2 Surgery Mature N 
4 b/o Nalini D1 3.2 F 767926 NVD N YES 1 Surgery Mature N 
5 B/O vanilla D6 3.0 F 762487 NVD N YES 2 Surgery Mature Increased 
6 b/o Jansi rani D1 2.0 F 751538 LSCS YES NIL 1 Surgery Mature N 
7 b/o Manjula D11 3.1 F 749890 LSCS YES YES 3 Surgery Mature N 
8 b/o Rahamida D24 3.0 F 746500 LSCS N YES 2 Sx & Chemo Immature increased 
9  Divya 1 yr 7.8 F 759505 LSCS NIL YES 3 Neo adj Chemo 
& Surgery 
Immature increased 
10 Rahul 1 Yr 8 M 743636 LSCS NIL Yes 3 Neo adj CT/RT Immature increased 
11 b/o Padmapriyan D3 3.0 F 767926 LSCS N YES 2 Surgery Mature N 
12 B/O Rochitha D1 3.2 F 746500 NVD N YES 1 Sx & CT Immature increased 
13 b/oKajanayabraul D1 3.0 F 739503 LSCS N YES 2 Surgery Mature N 
14 b/o Kalaiselvi D23 3.1 F 816607 LSCS YES YES 3 Surgery Mature N 
15 b/o Kokila 8 M 6.0 F 788420 LSCS NIL YES 3 Neo Adj CT/RT Immature N 
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